Question 1

What is Tarsus Pharmaceuticals?

Accepted Answer

Tarsus Pharmaceuticals is a Company.

Question 2

How often does Tarsus Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Tarsus Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 29, 2026.

Question 4

When was Tarsus Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Aug 06, 2026.

Question 5

What is Tarsus Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Tarsus Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Tarsus Pharmaceuticals?

Accepted Answer

Tarsus acquires iRenix Medical (Jul 08, 2026, 6 articles).

Question 8

How did the "Tarsus acquires iRenix Medical" event impact Tarsus Pharmaceuticals?

Accepted Answer

Acquirer; strengthens pipeline with late-stage asset IRX-101, expanding into retinal disease market.

Question 9

How did the "Tarsus Q2 2026 Results Webcast" event impact Tarsus Pharmaceuticals?

Accepted Answer

Tarsus Pharmaceuticals is the company hosting the earnings call. The event is a routine quarterly update; the impact will depend on the reported results and guidance.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.